Low-dose renin inhibitor and low-dose AT(1)-receptor blocker therapy ameliorate target-organ damage in rats harbouring human renin and angiotensinogen genes.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples